Repligen
RGEN
#2301
Rank
โ‚ฌ7.27 B
Marketcap
128,88ย โ‚ฌ
Share price
1.23%
Change (1 day)
21.52%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): โ‚ฌ72.33 Million

According to Repligen 's latest financial reports the company's current earnings are โ‚ฌ0.73 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ5.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ73.55 M-1430.84%
2024 -โ‚ฌ5.53 Million-113.01%
2023 โ‚ฌ42.47 M-78.01%
2022 โ‚ฌ0.19 B33.37%
2021 โ‚ฌ0.14 B131.52%
2020 โ‚ฌ62.55 M101.31%
2019 โ‚ฌ31.07 M25.93%
2018 โ‚ฌ24.67 M105.61%
2017 โ‚ฌ12 M-11.46%
2016 โ‚ฌ13.55 M14.91%
2015 โ‚ฌ11.79 M20.26%
2014 โ‚ฌ9.8 M-51.49%
2013 โ‚ฌ20.21 M90.98%
2012 โ‚ฌ10.58 M
2010 โ‚ฌ0.15 M-103.81%
2009 -โ‚ฌ4.03 Million-223.84%
2008 โ‚ฌ3.24 M
2006 -โ‚ฌ2.19 Million229.64%
2005 -โ‚ฌ0.67 Million-89.16%
2004 -โ‚ฌ6.11 Million-16.86%
2003 -โ‚ฌ7.35 Million88.72%
2002 -โ‚ฌ3.9 Million-27.88%
2001 -โ‚ฌ5.4 Million-1.74%
2000 -โ‚ฌ5.5 Million85.93%
1999 -โ‚ฌ2.96 Million159.16%
1998 -โ‚ฌ1.14 Million85.71%
1997 -โ‚ฌ0.62 Million-70.83%
1996 -โ‚ฌ2.11 Million-72.41%
1995 -โ‚ฌ7.63 Million-60.63%
1994 -โ‚ฌ19.38 Million45.39%
1993 -โ‚ฌ13.33 Million39.45%
1992 -โ‚ฌ9.56 Million-32.3%
1991 -โ‚ฌ14.12 Million6.62%
1990 -โ‚ฌ13.24 Million1577.78%
1989 -โ‚ฌ0.79 Million-57.14%
1988 -โ‚ฌ1.85 Million-362.5%
1987 โ‚ฌ0.7 M-130.77%
1986 -โ‚ฌ2.28 Million136.36%
1985 -โ‚ฌ0.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.28 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ6.50 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ9.62 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.41 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ95.59 Million-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.40 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.70 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.10 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚ฌ87.24 Million-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA